Ensysce Biosciences Announces Completion of $15 Million Convertible Note Financing
SAN DIEGO, Nov. 08, 2021 (GLOBE NEWSWIRE) -- Ensysce Biosciences, Inc. (“Ensysce” or the “Company”) (NASDAQ: ENSC, OTC: ENSCW), a...
Year: 2021
Phathom Pharmaceuticals Reports Third Quarter 2021 Results and Provides Key Clinical, Regulatory, and Business Updates
Two New Drug Applications (NDAs) for vonoprazan-based treatment regimens for H. pylori infection were accepted for filing by FDA with...
Crinetics Pharmaceuticals Presenting New Data from Open Label Extension Trial of Paltusotine in Acromegaly at the Society for Endocrinology BES Congress
SAN DIEGO, Nov. 08, 2021 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a clinical stage pharmaceutical company focused on...
VBL Therapeutics to Report Third Quarter Financial Results on November 15
TEL AVIV, Israel and NEW YORK, Nov. 08, 2021 (GLOBE NEWSWIRE) -- VBL Therapeutics (Nasdaq: VBLT), a clinical stage company developing...
CV Sciences, Inc. to Announce Third Quarter 2021 Results on November 15, 2021
SAN DIEGO, Nov. 08, 2021 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”),...
Quoin Pharmaceuticals Signs Exclusive Licensing and Distribution Agreement with AFT Pharmaceuticals for its Lead Asset, QRX003
AFT Gains Exclusive Rights to Commercialize QRX003 in Australia and New Zealand ASHBURN, Va., Nov. 08, 2021 (GLOBE NEWSWIRE) --...
Bolt Biotherapeutics to Present at Stifel 2021 Virtual Healthcare Conference
REDWOOD CITY, Calif., Nov. 08, 2021 (GLOBE NEWSWIRE) -- Bolt Biotherapeutics (Nasdaq: BOLT), a clinical-stage biotechnology company pioneering a new...
Neurona Therapeutics Presents Preclinical Data from Lead Cell Therapy Candidate NRTX-1001 at Neuroscience 2021
IND cleared by the FDA to enable initiation of Phase 1/2 clinical trial of NRTX-1001 in people with drug-resistant focal...
Talis Biomedical Granted FDA Emergency Use Authorization (EUA) for COVID-19 Molecular Point-of-Care Test to Detect SARS-CoV-2
Authorized for use in a variety of healthcare and congregate settings, Talis One™ enables lab-quality results without the wait to...
Ring Therapeutics Strengthens Leadership Team with Three Executive Appointments
Biotech pioneer appoints industry experts Yong S. Chang, Ph.D., as Chief Scientific Officer, John Huynh, Ph.D., as Senior Vice President...
Levitee Labs Signs LOI to Acquire Controlling Interest in a R&D Compounding Pharmacy; Focus to be on Levitee-Branded Products
Levitee Labs acquiring 51% interest in new R&D compounding pharmacy in Calgary, Alberta, CanadaNew pharmacy to focus on production of...
Keros Therapeutics to Present Results from a Preclinical Study of RKER-012 at the American Heart Association 2021 Scientific Sessions
LEXINGTON, Mass., Nov. 08, 2021 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. (“Keros”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on...
Recce Pharmaceuticals to Give Opening R&D Address at World Anti-Microbial Resistance Congress 2021
SYDNEY, Australia, Nov. 08, 2021 (GLOBE NEWSWIRE) -- Recce Pharmaceuticals Ltd (ASX:RCE, FSE:R9Q) (Company), the Company developing new classes of...
Ascendis Pharma A/S – Share Repurchase Program Update
COPENHAGEN, Denmark, Nov. 08, 2021 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today provided an update on the Company’s...
PepGen Bolsters R&D Team with Appointment of Jaya Goyal, Ph.D., as Executive Vice President of Research and Preclinical Development
BOSTON, Nov. 08, 2021 (GLOBE NEWSWIRE) -- PepGen, Inc., a company advancing next-generation oligonucleotide therapies for neuromuscular and neurologic diseases, today...
Alignment Healthcare Executive Dawn Maroney Honored with Top “Women in Business” Award by Orange County Business Journal
ORANGE, Calif., Nov. 08, 2021 (GLOBE NEWSWIRE) -- Alignment Healthcare (NASDAQ: ALHC), a mission-based Medicare Advantage insurance company, today announced...
LifeMD Launches Virtual Care Platform, Bringing Accessible, Affordable Healthcare to Patients Nationwide
Access to care 24/7 at affordable rates, a physician who knows you personally, unlimited messaging with dedicated medical team, and...
Impel NeuroPharma to Report Third Quarter 2021 Financial Results on Monday, November 15, 2021
SEATTLE, Nov. 08, 2021 (GLOBE NEWSWIRE) -- Impel NeuroPharma, Inc. (NASDAQ: IMPL), a commercial-stage biopharmaceutical company developing transformative therapies for...
Avadel Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2021 Financial Results
FDA review of NDA for FT218 ongoing; commercial and launch preparations progressingPresentation of new data from pivotal REST-ON clinical trial...
Jasper Therapeutics to Present at the Credit Suisse 30th Annual Virtual Healthcare Conference
REDWOOD CITY, Calif., Nov. 08, 2021 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (NASDAQ: JSPR), a biotechnology company focused on hematopoietic...
